Cargando…
In vitro antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues
The objective of this study is to evaluate a series of molecules based on cyclosulfamide as potential anticancer agents. Additionally, the study aims to analyze the obtained results through in silico studies; by conducting experiments and utilizing theoretical methods. In this context, we investigat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301704/ https://www.ncbi.nlm.nih.gov/pubmed/37388149 http://dx.doi.org/10.1039/d3ra02904b |
_version_ | 1785064875516493824 |
---|---|
author | Bouzina, Abdeslem Bouone, Yousra Ouafa Sekiou, Omar Aissaoui, Mohamed Ouk, Tan-Sothea Djemel, Abdelhak Mansouri, Rachida Ibrahim-Ouali, Malika Bouslama, Zihad Aouf, Nour-Eddine |
author_facet | Bouzina, Abdeslem Bouone, Yousra Ouafa Sekiou, Omar Aissaoui, Mohamed Ouk, Tan-Sothea Djemel, Abdelhak Mansouri, Rachida Ibrahim-Ouali, Malika Bouslama, Zihad Aouf, Nour-Eddine |
author_sort | Bouzina, Abdeslem |
collection | PubMed |
description | The objective of this study is to evaluate a series of molecules based on cyclosulfamide as potential anticancer agents. Additionally, the study aims to analyze the obtained results through in silico studies; by conducting experiments and utilizing theoretical methods. In this context, we investigated the cytotoxic activity of enastron analogues on three human cell lines PRI (lymphoblastic cell line) derived from B-cell lymphoma. JURKAT (ATCC TIB-152) acute T cell leukaemia and K562 (ATCC CLL-243) is a chronic myelogenous leukaemia. Most of the tested compounds showed good inhibitory activity compared with the reference ligand (chlorambucil). The 5a derivative demonstrated the strongest effect against all cancer cells used. Furthermore, molecular docking simulations of the Eg5–enastron analogue complex revealed that studied molecules have the ability to inhibit the Eg5 enzyme, as evidenced by their calculated docking score. Following the promising results from the molecular docking study, the complex Eg5–4a underwent a 100 ns molecular dynamics simulation using Desmond. During the simulation, the receptor-ligand pairing demonstrated substantial stability after the initial 70 ns. In addition, we used DFT calculations to analyze the electronic and geometric characteristics of the studied compounds. The HOMO and LUMO band gap energies, and the molecular electrostatic potential surface were also deducted for the stable structure of each compound. Also, we studied the prediction of absorption, distribution, metabolism and excretion (ADME) of the compounds. |
format | Online Article Text |
id | pubmed-10301704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-103017042023-06-29 In vitro antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues Bouzina, Abdeslem Bouone, Yousra Ouafa Sekiou, Omar Aissaoui, Mohamed Ouk, Tan-Sothea Djemel, Abdelhak Mansouri, Rachida Ibrahim-Ouali, Malika Bouslama, Zihad Aouf, Nour-Eddine RSC Adv Chemistry The objective of this study is to evaluate a series of molecules based on cyclosulfamide as potential anticancer agents. Additionally, the study aims to analyze the obtained results through in silico studies; by conducting experiments and utilizing theoretical methods. In this context, we investigated the cytotoxic activity of enastron analogues on three human cell lines PRI (lymphoblastic cell line) derived from B-cell lymphoma. JURKAT (ATCC TIB-152) acute T cell leukaemia and K562 (ATCC CLL-243) is a chronic myelogenous leukaemia. Most of the tested compounds showed good inhibitory activity compared with the reference ligand (chlorambucil). The 5a derivative demonstrated the strongest effect against all cancer cells used. Furthermore, molecular docking simulations of the Eg5–enastron analogue complex revealed that studied molecules have the ability to inhibit the Eg5 enzyme, as evidenced by their calculated docking score. Following the promising results from the molecular docking study, the complex Eg5–4a underwent a 100 ns molecular dynamics simulation using Desmond. During the simulation, the receptor-ligand pairing demonstrated substantial stability after the initial 70 ns. In addition, we used DFT calculations to analyze the electronic and geometric characteristics of the studied compounds. The HOMO and LUMO band gap energies, and the molecular electrostatic potential surface were also deducted for the stable structure of each compound. Also, we studied the prediction of absorption, distribution, metabolism and excretion (ADME) of the compounds. The Royal Society of Chemistry 2023-06-28 /pmc/articles/PMC10301704/ /pubmed/37388149 http://dx.doi.org/10.1039/d3ra02904b Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Chemistry Bouzina, Abdeslem Bouone, Yousra Ouafa Sekiou, Omar Aissaoui, Mohamed Ouk, Tan-Sothea Djemel, Abdelhak Mansouri, Rachida Ibrahim-Ouali, Malika Bouslama, Zihad Aouf, Nour-Eddine In vitro antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues |
title |
In vitro antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues |
title_full |
In vitro antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues |
title_fullStr |
In vitro antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues |
title_full_unstemmed |
In vitro antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues |
title_short |
In vitro antitumor activity, molecular dynamics simulation, DFT study, ADME prediction, and Eg5 binding of enastron analogues |
title_sort | in vitro antitumor activity, molecular dynamics simulation, dft study, adme prediction, and eg5 binding of enastron analogues |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301704/ https://www.ncbi.nlm.nih.gov/pubmed/37388149 http://dx.doi.org/10.1039/d3ra02904b |
work_keys_str_mv | AT bouzinaabdeslem invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues AT bouoneyousraouafa invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues AT sekiouomar invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues AT aissaouimohamed invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues AT ouktansothea invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues AT djemelabdelhak invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues AT mansourirachida invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues AT ibrahimoualimalika invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues AT bouslamazihad invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues AT aoufnoureddine invitroantitumoractivitymoleculardynamicssimulationdftstudyadmepredictionandeg5bindingofenastronanalogues |